BG101145A - Използване на /s/-аденозил-l-метионин /саме/ i неговите физиологично съвместими соли за лечение нареперфузионно увреждане, причинено от временна фокална исхемиа - Google Patents

Използване на /s/-аденозил-l-метионин /саме/ i неговите физиологично съвместими соли за лечение нареперфузионно увреждане, причинено от временна фокална исхемиа

Info

Publication number
BG101145A
BG101145A BG101145A BG10114597A BG101145A BG 101145 A BG101145 A BG 101145A BG 101145 A BG101145 A BG 101145A BG 10114597 A BG10114597 A BG 10114597A BG 101145 A BG101145 A BG 101145A
Authority
BG
Bulgaria
Prior art keywords
methyonine
adenosyl
caused
treatment
compatible salts
Prior art date
Application number
BG101145A
Other languages
Bulgarian (bg)
English (en)
Inventor
Laszlo Szabo
Original Assignee
Knoll Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Knoll Gmbh filed Critical Knoll Gmbh
Publication of BG101145A publication Critical patent/BG101145A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Cardiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
BG101145A 1994-07-16 1997-01-17 Използване на /s/-аденозил-l-метионин /саме/ i неговите физиологично съвместими соли за лечение нареперфузионно увреждане, причинено от временна фокална исхемиа BG101145A (bg)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4425280A DE4425280C2 (de) 1994-07-16 1994-07-16 Verwendung von (S)-Adenosyl-L-methionin und dessen physiologisch verträglichen Salzen zur Behandlung von Reperfusionsschäden, die nach temporärer fokaler Ischämie ausgelöst werden
PCT/EP1995/002598 WO1996002252A1 (de) 1994-07-16 1995-07-05 VERWENDUNG VON (S)-ADENOSYL-L-METHIONIN (SAMe) UND DESSEN PHYSIOLOGISCH VERTRÄGLICHEN SALZEN ZUR BEHANDLUNG VON REPERFUSIONSSCHÄDEN, DIE DURCH TEMPORÄRE FOKALE ISCHÄMIE AUSGELÖST WERDEN

Publications (1)

Publication Number Publication Date
BG101145A true BG101145A (bg) 1997-08-29

Family

ID=6523426

Family Applications (1)

Application Number Title Priority Date Filing Date
BG101145A BG101145A (bg) 1994-07-16 1997-01-17 Използване на /s/-аденозил-l-метионин /саме/ i неговите физиологично съвместими соли за лечение нареперфузионно увреждане, причинено от временна фокална исхемиа

Country Status (18)

Country Link
US (1) US5776911A (de)
EP (1) EP0771202A1 (de)
JP (1) JPH10502652A (de)
KR (1) KR970704442A (de)
AU (1) AU2927195A (de)
BG (1) BG101145A (de)
CA (1) CA2195345A1 (de)
CZ (1) CZ12297A3 (de)
DE (1) DE4425280C2 (de)
FI (1) FI970165A7 (de)
HR (1) HRP950405A2 (de)
HU (1) HUT76834A (de)
IL (1) IL114540A0 (de)
NO (1) NO970185L (de)
PL (1) PL318318A1 (de)
SI (1) SI9520087A (de)
WO (1) WO1996002252A1 (de)
ZA (1) ZA955865B (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19515275A1 (de) * 1995-04-26 1996-10-31 Knoll Ag Neue Verwendung von (S)-Adenosyl-L-methionin(SAMe)
IT1317920B1 (it) * 2000-10-20 2003-07-15 Univ Roma S-adenosilmetionina e suoi derivati per il trattamento e laprevenzione della malattia di alzheimer.
US8841344B2 (en) 2002-10-03 2014-09-23 Hill's Pet Nutrition, Inc. Method of using omega-3 fatty acids
FR2884421B1 (fr) 2005-04-15 2007-08-10 Virbac Sa Nouveaux moyens de regulation des troubles du comportement chez les animaux de compagnie
WO2006111541A2 (en) * 2005-04-20 2006-10-26 Basf Plant Science Gmbh Expression cassettes for seed-preferential expression in plants
US8618355B2 (en) 2008-03-17 2013-12-31 National Research Council Of Canada Aromatic prenyltransferase from hop

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1173990B (it) * 1984-05-16 1987-06-24 Bioresearch Spa Sali stabili della solfo-adenosil-l-metionina (same) particolarmente adatti per uso parenterale
JPH0770235B2 (ja) * 1988-06-24 1995-07-31 株式会社東芝 不揮発性メモリ回路装置
JPH02290896A (ja) * 1989-04-28 1990-11-30 Fuji Kagaku Kogyo Kk 新規なｓ―アデノシルメチオニン誘導体

Also Published As

Publication number Publication date
NO970185L (no) 1997-03-12
NO970185D0 (no) 1997-01-15
ZA955865B (en) 1997-01-14
CZ12297A3 (cs) 1998-04-15
MX9700439A (es) 1998-05-31
AU2927195A (en) 1996-02-16
DE4425280A1 (de) 1996-01-18
EP0771202A1 (de) 1997-05-07
WO1996002252A1 (de) 1996-02-01
HUT76834A (en) 1997-11-28
CA2195345A1 (en) 1996-02-01
KR970704442A (ko) 1997-09-06
HRP950405A2 (en) 1997-10-31
SI9520087A (en) 1997-08-31
US5776911A (en) 1998-07-07
HU9700130D0 (en) 1997-02-28
IL114540A0 (en) 1995-11-27
DE4425280C2 (de) 1997-05-07
FI970165L (fi) 1997-03-14
PL318318A1 (en) 1997-06-09
JPH10502652A (ja) 1998-03-10
FI970165A7 (fi) 1997-03-14
FI970165A0 (fi) 1997-01-15

Similar Documents

Publication Publication Date Title
DE60019473D1 (de) (S,S)-Reboxetin zur Behandlung von peripheren Neuropathien
ATE342728T1 (de) Zubereitung zur behandlung von einer neurologischen erkrankung
DE69925256D1 (de) Trisubstituierte 1,3,5-triazine derivate zur behandlung von hiv infektionen
SV1995000007A (es) Derivados del acido micofenolico 5-substituidos.
AP2000001942A0 (en) Use of organophosphoric compounds for the therapeutic and preventative treatment of infections.
MY155218A (en) Small molecules useful in the treatment of inflammatory disease
ES2160707T3 (es) Composiciones que comprenden agentes deteriorantes del adn y p53.
EA200200742A1 (ru) 1,2-диарилбензимидазолы для лечения заболеваний, связанных с активацией микроглии
EP0932613A4 (de) Expressionsblockierung von virulenten faktoren in s. aureus
DE3782214D1 (de) Mittel zur behandlung des scheidenmilieus.
DE60115466D1 (de) Wirkstoffvorläufer von imidazopyridin-derivaten
ID24184A (id) Obat untuk perawatan disfungsi ereksi
NO911429L (no) Stoffbehandling.
IT1290781B1 (it) Agente attivo terapeutico per il trattamento di malattie degenerative neuronali.
BG101145A (bg) Използване на /s/-аденозил-l-метионин /саме/ i неговите физиологично съвместими соли за лечение нареперфузионно увреждане, причинено от временна фокална исхемиа
MY124071A (en) Treatment of viral disease in swine
NO911430L (no) Stoffbehandlingsmetode.
ES2144857T3 (es) Utilizacion de derivados benzonaftalenicos para la fabricacion de medicamentos destinados para el tratamiento de las enfermedades del sistema nervioso.
RU99111064A (ru) Средство для лечения и профилактики инфекционных заболеваний и отравлений животных и птиц, повышающее их продуктивность и сохранность
DE60124093D1 (de) S-methyl-dihydro-ziprasidon zur Behandlung von Augenerkrankungen.
DE69737088D1 (de) Therapeutisches agens zur behandlung von fiv infektionen
IT240104Y1 (it) Dispositivo per il trattamento del corpo umano.
ES2171838T3 (es) Uso de 3-(4-hexiloxi-1,2,5-tiadiazol-3-il)-1,2,5,6-tetrahidro-1-metilpiridina (xanomelina) para el tratamiento del trastorno bipolar.
BR0008791A (pt) Derivados anticonvulsivos, úteis no tratamento de tremor essencial
EP1406605A4 (de) Carbamate von 2-heterozyklischen 1,2-ethandiolen